Category Specific RSS

ASX:MEM

Memphasys Delivers Clinical Milestone as Felix™ Fertility System Clears Key Trial Benchmark

Fertility Tech Market Expands, With Memphasys Ready to Capitalise The global assisted reproductive technology (ART) sector continues to grow rapidly,…

10 months ago

Memphasys Reaches Key Milestone in Felix™ Clinical Trial, Data Lock Expected Soon

Advanced Sperm Selection Technology Moves Closer to Market Memphasys Limited (ASX:MEM) has hit a critical milestone in its pivotal clinical…

12 months ago